[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100509309":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":29,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Male IBD patients",null,"Male patients with a confirmed diagnosis of Inflammatory Bowel Disease (Crohn´s disease or Ulcerative colitis).",[13],"Diagnostic Test: Anal pap smear and oral swab for cytology and HPV testing",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","Anal pap smear and oral swab for cytology and HPV testing","Anal and oral swab sampling for HPV detection (polymerase chain reaction) and cytology",[9],[21],{"name":22,"affiliation":23,"role":24},"Antonio Giordano, MD","dr.antoniogiordano@gmail.com","PRINCIPAL_INVESTIGATOR",[26],{"name":22,"role":27,"phone":28,"phoneExt":10,"email":23},"CONTACT","0034 932919000",[30],{"facility":5,"status":31,"city":32,"state":10,"zip":10,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"RECRUITING","Barcelona","Spain","ES",{"type":36,"coordinates":37},"Point",[38,39],2.15899,41.38879,{"lat":39,"lon":38},[42,45],{"name":43,"role":27,"phone":10,"phoneExt":10,"email":44},"Antonio Giordano, PhD","inflamatoria@santpau.cat",{"name":43,"role":24,"phone":10,"phoneExt":10,"email":10},{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100509309","prevalence-and-clinical-implications-of-hpv-infection-in-male-ibd-patients-100509309",false,"NCT05911750","Prevalence and Clinical Implications of HPV Infection in Male IBD Patients","Prevalence and Clinical Implications of Human Papillomavirus Infection in the Male Population With Inflammatory Bowel Disease","PAPIMALE","Inclusion Criteria:\n\n* Diagnosed Crohn's disease or ulcerative colitis (at least 3 months before enrollment)\n* Male\n* Age from 18 to 79 years\n\nExclusion Criteria:\n\n* Unclassified Inflammatory Bowel Disease\n* Diarrhea (\\> 3 bowel movements\u002Fday) with rectal bleeding at enrollment\n* Prior full proctectomy\n* Inability to collect the biological samples\n* Inability to complete the questionnaire\n* Refusal to sign the informed consent","MALE","18 Years","79 Years",{"count":60,"type":61},384,"ESTIMATED","OBSERVATIONAL","The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.",[65,66,67],"HPV Infection","Dysplasia Anus","Oral Cavity Disease",[69],"HPV, oral swab, anal swab","2025-09-08",{"date":72,"type":73},"2025-09-12","ACTUAL",{"date":75,"type":73},"2023-02-12",{"date":77,"type":61},"2026-06-01",{"name":5,"class":6},1]